alpha-1-antitrypsin deficiency
Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
6
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
14
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
9
Alpha -1-antitrypsin deficiency, associated diseases and treatments: a review
7
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
12
Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
7
Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
5
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
9
Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values
10
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
15
<p>New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency</p>
11
Heterozygous Alpha-1-Antitrypsin Deficiency and Respiratory Function in Children
12
Alternative transcripts of the SERPINA1 gene in alpha 1 antitrypsin deficiency
11
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
9
Recombinant DNA produced alpha 1 antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1 antitrypsin deficiency
7
Association of IREB2 and CHRNA3polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency
7
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
10
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
9
The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency
8
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
14